Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07641933Phase 1Recruiting
Phase 1, randomised trial of TheraCal and sodium hypochlorite in Periapical Abscess (3 arms), sponsored by Ain Shams University. Primary endpoint: Biological Evaluation of inflammatory marker (IL-1B) at 14 days. Started Jun 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07641933.